Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Metals & Mining Virtual Investor Conference Agenda Announced...

July 23, 2025

Sun Summit Minerals

July 3, 2025

Metals Focus: Gold to Average US$3,210 in 2025...

June 6, 2025

5 Best-performing Copper Stocks on the TSX in...

July 23, 2025

Ore Reserve Quadruples for Rhyolite Ridge Project; Reaffirms...

June 2, 2025

Osisko Metals

July 19, 2025

Juggernaut Files for Approval of Private Placement Financing

June 13, 2025

Comet share sale and debt repayment

July 28, 2025

Syntheia Announces Closing of Private Placement

June 18, 2025

Strong Leach Recoveries and Low Impurities

July 9, 2025